Goose, I'm going to guess $285.00. I believe once the drug is approved we will have all the gov funding we would ever need. I'm thinking stock piling and then of course the rest of the world. By the end of year I say ~$400.00
3-4 years out with all of the immune response related indications $2000.00.

I know this sounds crazy and probably years away but with a safety profile like Leronlimab I could see it as an OTC med with an easy delivery system, with a general indication for "over active Immune response related to Viral and bacterial infections ( I'm thinking Lyme disease also including Cancer, Alzheimers, ad infinitum. Wild idea I know!